Remdesivir
Remdesivir, a drug previously tested on Ebola patients, resulted in 53% of the patients dying.
Covid-19 has a 99.97% survival rate.
On November 20, 2020, the WHO (World Health Organization) announced their recommendation, based on data collected from over 7,000 patients, AGAINST the use of Remdesivir in Covid-19 patients "regardless of disease severity, as there is currently no evidence that Remdesivir improves survival and other outcomes in these patients." Nevertheless, hospitals continue to administer this toxic drug to patients as part of the Remdesivir protocol resulting in significant injury or death.
Many patients and families begged that Remdesivir not be used but the hospitals went ahead and administered it against their wishes. As it turns out, there are substantial financial incentives for hospitals when they use this protocol with Covid patients.
Nationwide
After filing the lawsuits in Fresno, California (14 families against 3 hospitals), we had over 1,000 people reach out to us telling of eerily similar treatment and deaths. We have heard from people in each of the 50 states. We now have lawsuits pending in 5 other states (Texas, Kentucky, Arizona, Maryland, and Nevada) for families who suffered the same tragic fate as so many of their fellow Americans. We would appreciate any help as we attempt to help families across the United States until these hospitals stop treating with the Remdesivir protocol.
Fresno, CA
Families who lost loved ones as a result of the Remdesivir protocol now fight to bring awareness to what is happening, stop the use of Remdesivir and to hold the hospitals and doctors accountable for their wrongs, as they miss their loved ones who have passed. Lawsuits filed against hospitals in Fresno County, California on behalf of 14 families.